Alendronate-d4 (sodium)

Alendronate-d4 (sodium) (Alendronic acid-d4 (monosodium salt) ) is deuterium labeled Alendronate sodium. Alendronate sodium is an orally active nitrogen-containing bisphosphonate. Alendronate sodium potently inhibits bone resorption. Alendronate sodium is used for the research of postmenopausal osteoporosis[1].

Product Specifications

CAS Number

[1309283-09-7]

Product Name Alternative

Alendronic acid-d4 (monosodium salt)

UNSPSC

12352211

Target

Isotope-Labeled Compounds

Related Pathways

Others

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Metabolic Disease; Cancer

Smiles

O=P(O)(O)C(CC([2H])([2H])C([2H])([2H])N)(O)P(O)(O)=O

Molecular Formula

C4H9D4NO7P2

Molecular Weight

253.12

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Imai K. Alendronate sodium hydrate (oral jelly) for the treatment of osteoporosis: review of a novel, easy to swallow formulation. Clin Interv Aging. 2013;8:681-688.